This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Apollo, Opnext: After-Hours Trading (Update 1)

Updated from 5:18 p.m. ET for latest share prices, additional information on Opnext and Ista Pharmaceuticals.

NEW YORK ( TheStreet) -- Shares of Apollo Group (APOL - Get Report) turned lower in late trades on Monday despite the for-profit education company trouncing Wall Street expectations for its fiscal second-quarter results.

The Phoenix-based company reported earnings from continuing operations excluding items of $73.8 million, or 58 cents a share, for the three months ended Feb. 29 on revenue of $969.6 million. The average estimate of analysts polled by Thomson Reuters was for a profit of 37 cents a share in the quarter on revenue of $933.3 million.

Apollo, which operates the University of Phoenix, said new degreed enrollment was up 1.0% year-over-year, and that total enrollment stood at 355,800 at quarter's end.



The stock was last quoted at $41.50, down 4%, on volume of nearly 600,000, according to Nasdaq.com, and it has ranged as high as $47.06 and as low as $40.81. Based on Monday's regular-session close at $43.20, the shares were down more than 20% so far in 2012.

Apollo also forecast operating income excluding items of $625 million to $725 million for fiscal 2012 on revenue ranging from $4.1 billion to $4.3 billion.

Check out TheStreet's quote page for Apollo Group for year-to-date share performance, analyst ratings, earnings estimates and much more.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
APOL $16.46 0.00%
NBIX $42.55 0.00%
OCLR $2.20 0.00%
AAPL $132.54 0.00%
FB $80.54 0.00%

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs